|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |review |
 |
Using the framework presented, consider the following issue:
In 2007, in your country, you would like to design a trial to examine the
efficacy of statin use in the treatment regimes in diabetics.
What are the ethical issues you must consider?
|